Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

1. The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.Drug safety · 2026
   Review
2. Pre-hospital oxygen therapy and saturation variability in COVID-19 patients with and without glucose metabolism disorders: part of the COLOS Study.Scientific reports · 2024
   Article
3. Histopathological impact of SARS-CoV-2 on the liver: Cellular damage and long-term complications.World journal of gastroenterology · 2024
   Review
4. The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence.Viruses · 2023
   Review
5. COVID-19 and liver diseases.Egyptian liver journal · 2022
   Review
6. Percutaneous microwave ablation applications for liver tumors: recommendations for COVID-19 patients.Heliyon · 2021
   Review
7. COVID-19-associated liver injury: from bedside to bench.Journal of gastroenterology · 2021
   Review
8. Hunting coronavirus by transmission electron microscopy - a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues.Histopathology · 2021
   Review

Corrections and comments

• Comment on
  SARS-CoV-2 related liver impairment - perception may not be the reality.2020
• Comment on
  Single cell RNA sequencing analysis did not predict hepatocyte infection by SARS-CoV-2.2020
• Comment on
  SARS-CoV-2: Is the liver merely a bystander to severe disease?2020

Authors and funding

3 authors at 2 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as